Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43146 (
tumour suppressor
)
5,935
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
DNA topoisomerase (topo) II modulates DNA topology and is essential for cell division. There are two isoforms of topo II (alpha and beta) that have limited functional redundancy, although their catalytic mechanisms appear the same. Using their COOH-terminal domains (CTDs) in yeast two-hybrid analysis, we have identified
phospholipid scramblase 1
(
PLSCR1
) as a binding partner of both topo II alpha and beta. Although predominantly a plasma membrane protein involved in phosphatidylserine externalization,
PLSCR1
can also be imported into the nucleus where it may have a
tumour suppressor
function. The interactions of
PLSCR1
and topo II were confirmed by pull-down assays with topo II alpha and beta CTD fusion proteins and endogenous
PLSCR1
, and by co-immunoprecipitation of endogenous
PLSCR1
and topo II alpha and beta from HeLa cell nuclear extracts.
PLSCR1
also increased the decatenation activity of human topo IIalpha. A conserved basic sequence in the CTD of topo IIalpha was identified as being essential for binding to
PLSCR1
and binding of the two proteins could be inhibited by a synthetic peptide corresponding to topo IIalpha amino acids 1430-1441. These studies reveal for the first time a physical and functional interaction between topo II and
PLSCR1
.
...
PMID:Nuclear interactions of topoisomerase II alpha and beta with phospholipid scramblase 1. 1756 3